Michael B. Bottorff
Impact in
- Family Practice top 5%
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
Papers in
- Pharmacology 14
- Pharmacogenetics and Drug Metabolism 11
- Antibiotics Pharmacokinetics and Efficacy 9
- Co-authors
- Philip D. HanstenPeter P. TóthPranav GandhiWilliam M. GentryRichard L. LalondeDavid W. BakerEric A. RoseRobert J. Luchi
- Journals
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (12 papers)Clinical Pharmacology & Therapeutics (7 papers)The Journal of Pediatrics (3 papers)Clinical Pharmacokinetics (3 papers)Therapeutic Drug Monitoring (2 papers)
- Partner nations
- United StatesIsrael
In The Last Decade
Michael B. Bottorff
65 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 114
- Family Practice 67
- Cardiology and Cardiovascular Medicine 574
- Geriatrics and Gerontology 89
- Pharmacology 158
- Surgery 432
Countries citing papers authored by Michael B. Bottorff
This map shows the geographic impact of Michael B. Bottorff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael B. Bottorff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael B. Bottorff more than expected).
Fields of papers citing papers by Michael B. Bottorff
This network shows the impact of papers produced by Michael B. Bottorff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael B. Bottorff. The network helps show where Michael B. Bottorff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael B. Bottorff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2020 | 30 | |
| 3 | 2006 | 6 | |
| 4 | 2003 | 6 | |
| 5 | 2003 | 14 | |
| 6 | 2002 | 1 | |
| 7 | 2001 | 21 | |
| 8 | 2000 | 98 | |
| 9 | 1997 | 13 | |
| 10 | 1996 | 27 | |
| 11 | 1991 | 36 | |
| 12 | Pharmacokinetics and pharmacodynamics of dilevalol alone and with cimetidine | 1989 | 4 |
| 13 | 1989 | 4 | |
| 14 | 1989 | 8 | |
| 15 | 1989 | 21 | |
| 16 | 1988 | 7 | |
| 17 | 1987 | 21 | |
| 18 | 1987 | 11 | |
| 19 | Na/K ATPase inhibition by digitalis-like factors in neonates | 1986 | 1 |
| 20 | 1984 | 8 |
About Michael B. Bottorff
Michael B. Bottorff is a scholar working on Pharmacology, Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine, Pharmacology and Analytical Chemistry, having authored 67 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Lipoproteins and Cardiovascular Health (11 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Analytical Methods in Pharmaceuticals (8 papers), Cardiac electrophysiology and arrhythmias (7 papers), Ion channel regulation and function (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). The work is most often cited by research in Family Practice (67 citations), Cardiology and Cardiovascular Medicine (574 citations), Geriatrics and Gerontology (89 citations), Pharmacology (158 citations) and Surgery (432 citations). Michael B. Bottorff has collaborated with scholars based in United States and Israel. Frequent co-authors include Philip D. Hansten, Peter P. Tóth, Pranav Gandhi, William M. Gentry, Richard L. Lalonde, David W. Baker, Eric A. Rose, Robert J. Luchi, David C. Hadorn and Mariell Jessup. Their work appears in journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Clinical Pharmacology & Therapeutics, The Journal of Pediatrics, Clinical Pharmacokinetics and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.